These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38541898)

  • 21. Ranolazine refractory angina registry: 1-year results.
    Bennett NM; Iyer V; Arndt TL; Garberich RF; Traverse JH; Johnson RK; Poulose AK; Lips A; Morgan JM; Henry TD
    Crit Pathw Cardiol; 2014 Sep; 13(3):96-8. PubMed ID: 25062392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ranolazine: a review of its use as add-on therapy in patients with chronic stable angina pectoris.
    Keating GM
    Drugs; 2013 Jan; 73(1):55-73. PubMed ID: 23329466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The usefulness of ranolazine for the treatment of refractory chronic stable angina pectoris as determined from a systematic review of randomized controlled trials.
    Banon D; Filion KB; Budlovsky T; Franck C; Eisenberg MJ
    Am J Cardiol; 2014 Mar; 113(6):1075-82. PubMed ID: 24462341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ranolazine Reduces Angina in Women with Ischemic Heart Disease: Results of an Open-Label, Multicenter Trial.
    Mehta PK; Sharma S; Minissian M; Harsch MR; Martinson M; Nyman JA; Shaw LJ; Bairey Merz CN; Wenger NK
    J Womens Health (Larchmt); 2019 May; 28(5):573-582. PubMed ID: 30888919
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial.
    Arnold SV; Morrow DA; Wang K; Lei Y; Mahoney EM; Scirica BM; Braunwald E; Cohen DJ;
    Circ Cardiovasc Qual Outcomes; 2008 Nov; 1(2):107-15. PubMed ID: 20031797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial.
    Alexander KP; Weisz G; Prather K; James S; Mark DB; Anstrom KJ; Davidson-Ray L; Witkowski A; Mulkay AJ; Osmukhina A; Farzaneh-Far R; Ben-Yehuda O; Stone GW; Ohman EM
    Circulation; 2016 Jan; 133(1):39-47. PubMed ID: 26555329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term safety of a novel antianginal agent in patients with severe chronic stable angina: the Ranolazine Open Label Experience (ROLE).
    Koren MJ; Crager MR; Sweeney M
    J Am Coll Cardiol; 2007 Mar; 49(10):1027-34. PubMed ID: 17349881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ranolazine: a better understanding of its pathophysiology and patient profile to guide treatment of chronic stable angina.
    Tamargo J; Lopez-Sendon J
    Future Cardiol; 2022 Mar; 18(3):235-251. PubMed ID: 34841884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and Safety of Ivabradine in Combination with Beta-Blockers in Patients with Stable Angina Pectoris: A Systematic Review and Meta-analysis.
    Nedoshivin A; Petrova PTS; Karpov Y
    Adv Ther; 2022 Sep; 39(9):4189-4204. PubMed ID: 35842897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ranolazine: a review of its use in chronic stable angina pectoris.
    Keating GM
    Drugs; 2008; 68(17):2483-503. PubMed ID: 19016575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of ranolazine added to standard-of-care treatment in patients with chronic stable angina pectoris.
    Kohn CG; Parker MW; Limone BL; Coleman CI
    Am J Cardiol; 2014 Apr; 113(8):1306-11. PubMed ID: 24560062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective.
    Coleman CI; Freemantle N; Kohn CG
    BMJ Open; 2015 Nov; 5(11):e008861. PubMed ID: 26546142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ranolazine: a review of its use in chronic stable angina pectoris.
    Siddiqui MA; Keam SJ
    Drugs; 2006; 66(5):693-710. PubMed ID: 16620147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-utility of ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Spain.
    Hidalgo-Vega A; Ramos-Goñi JM; Villoro R
    Eur J Health Econ; 2014 Dec; 15(9):917-25. PubMed ID: 24122303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spotlight on ranolazine in chronic stable angina pectoris.
    Siddiqui MA; Keam SJ
    Am J Cardiovasc Drugs; 2006; 6(5):357-9. PubMed ID: 17083271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ranolazine in the management of chronic stable angina.
    Zerumsky K; McBride BF
    Am J Health Syst Pharm; 2006 Dec; 63(23):2331-8. PubMed ID: 17106005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness and Tolerability of Trimetazidine 80 Mg Once Daily in Patients with Stable Angina Uncontrolled with Bisoprolol-Based Therapy: The Modus Vivendi Observational Study.
    Lopatin Y; Petrova P;
    Cardiol Ther; 2022 Mar; 11(1):93-111. PubMed ID: 34958427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center.
    Argirò A; Zampieri M; Dei LL; Ferrantini C; Marchi A; Tomberli A; Baldini K; Cappelli F; Favilli S; Passantino S; Zocchi C; Tassetti L; Gabriele M; Maurizi N; Marchionni N; Coppini R; Olivotto I
    Int J Cardiol; 2023 Jan; 370():271-278. PubMed ID: 36228766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of Stable Angina with a New Fixed-Dose Combination of Ivabradine and Metoprolol: Effectiveness and Tolerability in Routine Clinical Practice.
    Divchev D; Stöckl G;
    Cardiol Ther; 2017 Dec; 6(2):239-249. PubMed ID: 29116618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender comparison of efficacy and safety of ranolazine for chronic angina pectoris in four randomized clinical trials.
    Wenger NK; Chaitman B; Vetrovec GW
    Am J Cardiol; 2007 Jan; 99(1):11-8. PubMed ID: 17196454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.